GSK plc Contingent Liabilities Recognised In Business Combination
GSK plc (GSK) had Contingent Liabilities Recognised In Business Combination of GBP 6.73 billion as of 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination · last filed 2026-03-06
- 2025-12-31: Contingent Liabilities Recognised In Business Combination 6.73B GBP.
- 2024-12-31: Contingent Liabilities Recognised In Business Combination 7.28B GBP.
- 2023-12-31: Contingent Liabilities Recognised In Business Combination 6.66B GBP.
- 2022-12-31: Contingent Liabilities Recognised In Business Combination 7.07B GBP.
| Period end | Contingent Liabilities Recognised In Business Combination |
|---|---|
| 2025-12-31 | 6.73B GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 7.28B GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 6.66B GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 7.07B GBP 20-F · filed 2026-03-06 |
| 2021-12-31 | 6.08B GBP 20-F · filed 2025-03-03 |
| 2020-12-31 | 5.87B GBP 20-F · filed 2024-03-05 |
| 2019-12-31 | 5.48B GBP 20-F · filed 2023-03-10 |
| 2018-12-31 | 6.29B GBP 20-F · filed 2022-03-08 |
| 2017-12-31 | 6.17B GBP 20-F · filed 2021-03-12 |
| 2016-12-31 | 5.90B GBP 20-F · filed 2020-03-06 |
| 2015-12-31 | 3.85B GBP 20-F · filed 2019-03-15 |
| 2014-12-31 | 1.72B GBP 20-F/A · filed 2018-03-20 |